Utama › Kanser Pundi Kencing › Maryland › Baltimore
Kajian klinikal Kanser Pundi Kencing di Baltimore, MD
24 kajian untuk Kanser Pundi Kencing sedang mencari peserta di lokasi dalam dan sekitar Baltimore (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Mengambil pesertaFasa 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- dan 2 lagi
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- Johns Hopkins University, Baltimore
DK222 Study at Hopkins
Mengambil pesertaFasa 1
- Johns Hopkins Hospital, Baltimore
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Mengambil pesertaFasa 1/2
- Oncology Research Pharmacy and lnvestigational Drug Service, Baltimore
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Johns Hopkins Hospital, Baltimore
- dan 2 lagi
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Mengambil pesertaFasa 3
- Johns Hopkins University ( Site 0843), Baltimore
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Mengambil pesertaFasa 3
- Johns Hopkins Hospital, Baltimore
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Mengambil pesertaFasa 2
- Anne Arundel Urology, Annapolis · 22 mi jauh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Mengambil pesertaFasa 1
- Johns Hopkins Kimmel Cancer Center, Baltimore
Measuring Surgical Recovery After Radical Cystectomy
Mengambil pesertaKajian pemerhatian
- John Hopkins Medical Institutions, Baltimore
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Mengambil pesertaFasa 1/2
- John Hopkins Hospital, Baltimore
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Mengambil pesertaFasa 2/3
- Johns Hopkins Hospital, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- The John Hopkins Hospital, Baltimore
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Mengambil pesertaFasa 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Bladder EpiCheck Product Development Study
Mengambil pesertaKajian pemerhatian
- Chesapeake Urology Research Associates, Towson · 8 mi jauh
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Mengambil pesertaFasa 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Renal Retention in High Grade Upper Tract Urothelial Cancer
Mengambil pesertaFasa 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Image-Guided Gynecologic Brachytherapy
Mengambil peserta
- The SKCCC at Johns Hopkins, Baltimore
Blue Light Cystoscopy With Cysview® Registry
Mengambil pesertaKajian pemerhatian
- Johns Hopkins Medicine, Baltimore
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Mengambil peserta
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Hospital, Baltimore
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
Mengambil pesertaFasa 3
- Johns Hopkins University School of Medicine, Baltimore
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Mengambil peserta
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi jauh
Gender Related Coping and Survivorship for Genitourinary Cancers
Mengambil pesertaKajian pemerhatian
- Johns Hopkins Hospital, Baltimore
Kajian Kanser Pundi Kencing di bandar lain
- New York City, NY35 kajian
- Nashville, TN31 kajian
- Houston, TX31 kajian
- Dallas, TX27 kajian
- Boston, MA26 kajian
- Washington, DC26 kajian
- Los Angeles, CA24 kajian
- St. Louis, MO22 kajian
- Philadelphia, PA21 kajian
- Seattle, WA21 kajian
- Edison, NJ21 kajian
- Chicago, IL21 kajian
Kajian lain di Baltimore
- Kanser Paru-paru Bukan Sel Kecil60 kajian
- Kanser Payudara47 kajian
- Kanser Prostat43 kajian
- Kanser Paru-paru40 kajian
- Kanser (semua jenis)37 kajian
- Kanser Kolorektal31 kajian
- Kanser Pankreas31 kajian
- Kanser Metastatik28 kajian
- Obesiti25 kajian
- Kegagalan Jantung24 kajian
- Strok22 kajian
- Kanser Ovari22 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.